Report has been added to MarketsandMarkets offering The report "Needle-Free Injection System Market by Technology (Jet, Spring, Micro-array Patch), by Product (Prefilled, Fillable), Type of Medication (Liquid, Powder), Application (Vaccination, Dermatology), End Users (Hospital, Homecare) - Global Forecast to 2026

Get Sample Copy of This Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2020 to 2026. The high adoption of advanced drug delivery technologies across the globe is supporting the growth of this market.

Fillable segment accounted for the largest share in the needle-free injection system market.

vaccine delivery is estimated to account for the largest share of 32.8% of the needle-free injection system market by application. The rising prevalence of chronic diseases and infectious diseases worldwide has increased the demand for vaccination in the considered year and the increasing demand for patient-centric care are the major factors driving the growth of the needle-free injection market by application.

liquid-based injectors segment accounted for the largest share in the needle-free injection system market.

The liquid-based segment accounted for the largest share of 70.9% of the needle-free injection system market. The large share of this segment can be attributed to the ability of a liquid jet, which is stronger enough to penetrate the skin and the underlying fat layer without harming the skin or the integrity of the drug molecule.

Hospitals & clinics segment accounted for the largest share in the needle-free injection system market.

The hospitals & clinics segment accounted for the largest market share of 61.0% in 2020. Factors such as technological advancements and an increase in demand for vaccination are driving the growth of the hospitals & clinics segment.

Enquire Before Buying this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=165815861

North America accounted segment accounted for the largest share in the needle-free injection system market.

North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period.

Premium Insights

• The breast cancer testing segment accounts for the largest share of the market
• Rising acceptance of POC diagnostics and PST practices is expected to drive the growth of this regional segment during the forecast period.

Market Dynamics

Drivers

• High prevalence of infectious diseases globally
• Increasing incidence of communicable diseases due to needlestick injuries
• Rise in demand for self-injection devices
• Increased number of technological advancements
• Reduction in injection system costs

Opportunity

• Rising demand for biosimilars and vaccination processes
• Increasing number of emerging markets

Challenges

• Rise in need to ensure system sterility
• Growth in alternative modes of drug delivery

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Needle-free Injection System, by Application

7 Needle-free Injection System, by End-user

8 Needle-free Injection System, by region

9 Competitive Landscape

10 Company Profiles

11 Appendix

Buy Now Full Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=165815861